Marcus Svedberg1, Per M Gustafsson2, Paul D Robinson3, Monica Rosberg4, Anders Lindblad5. 1. Department of Pediatrics, Queen Silvia's Children Hospital, Gothenburg, Sweden. Electronic address: marcus.svedberg@vgregion.se. 2. Department of Pediatrics, Central Hospital, Skoevde, Sweden. 3. Department of Respiratory Medicine, The Children's Hospital at Westmead, Westmead, NSW, Australia; Discipline of Paediatrics and Child Health, The Children's Hospital at Westmead Clinical School, University of Sydney, Sydney, Australia. 4. Department of Clinical Physiology, Queen Silvia's Children Hospital, Gothenburg, Sweden. 5. Department of Pediatrics, Queen Silvia's Children Hospital, Gothenburg, Sweden.
Abstract
BACKGROUND: Data on long term variability of Lung Clearance Index (LCI) in Cystic Fibrosis (CF) is urgently needed to guide test result interpretation. Our aim was to evaluate LCI variability in clinically stable CF lung disease in school age children. METHODS: Paediatric patients, aged 6 to 17years, attending the outpatient CF clinic performed Multiple Breath Nitrogen Washout (Exhalyzer® D) and spirometry every third month over a period of one year. Clinical stability was assessed by the Cystic Fibrosis Clinical Score (CFCS) at each visit. RESULTS: Twentyfive children were recruited: baseline median (range) FEV1% pred. 91 (55-122)%, LCI 9.1 (6.4-18.6), CFCS 15 (12-23). A total of 107 visits were included in the study, of which 93% were defined as clinically stable. In clinically stable visits, within-subject variability of LCI and FEV1% pred. were 10% and 16%, respectively. The upper limit of normal (ULN, 95% percentile) of LCI variability during clinical stability was 17%. CONCLUSIONS: LCI within-subject variability was low and comparable to FEV1% pred. which strengthen the use of LCI to monitor lung disease progression in CF patients. An increase in LCI >17% compared to previous LCI-measurement in clinically stable CF patients may therefore indicate early lung disease progression.
BACKGROUND: Data on long term variability of Lung Clearance Index (LCI) in Cystic Fibrosis (CF) is urgently needed to guide test result interpretation. Our aim was to evaluate LCI variability in clinically stable CF lung disease in school age children. METHODS: Paediatric patients, aged 6 to 17years, attending the outpatient CF clinic performed Multiple Breath Nitrogen Washout (Exhalyzer® D) and spirometry every third month over a period of one year. Clinical stability was assessed by the Cystic Fibrosis Clinical Score (CFCS) at each visit. RESULTS: Twentyfive children were recruited: baseline median (range) FEV1% pred. 91 (55-122)%, LCI 9.1 (6.4-18.6), CFCS 15 (12-23). A total of 107 visits were included in the study, of which 93% were defined as clinically stable. In clinically stable visits, within-subject variability of LCI and FEV1% pred. were 10% and 16%, respectively. The upper limit of normal (ULN, 95% percentile) of LCI variability during clinical stability was 17%. CONCLUSIONS:LCI within-subject variability was low and comparable to FEV1% pred. which strengthen the use of LCI to monitor lung disease progression in CF patients. An increase in LCI >17% compared to previous LCI-measurement in clinically stable CF patients may therefore indicate early lung disease progression.
Authors: Kevin J O'Sullivan; Valerie Power; Barry Linnane; Deirdre McGrath; Magdalena Mulligan; Rebecca White; Leonard W O'Sullivan; Colum P Dunne Journal: BMC Pulm Med Date: 2021-05-12 Impact factor: 3.317
Authors: I Wojsyk-Banaszak; P Sobkowiak; K Jończyk-Potoczna; B Narożna; W Langwiński; M Szczepanik; Z Kycler; A Bręborowicz; A Szczepankiewicz Journal: Mediators Inflamm Date: 2019-10-16 Impact factor: 4.711
Authors: Katherine O'Neill; Kathryn Ferguson; Denis Cosgrove; Michael M Tunney; Anthony De Soyza; Mary Carroll; James D Chalmers; Timothy Gatheral; Adam T Hill; John R Hurst; Christopher Johnson; Michael R Loebinger; Gerhild Angyalosi; Charles S Haworth; Renee Jensen; Felix Ratjen; Clare Saunders; Christopher Short; Jane C Davies; J Stuart Elborn; Judy M Bradley Journal: ERJ Open Res Date: 2020-10-13
Authors: Alex R Horsley; John Belcher; Katie Bayfield; Brooke Bianco; Steve Cunningham; Catherine Fullwood; Andrew Jones; Anna Shawcross; Jaclyn A Smith; Anirban Maitra; Francis J Gilchrist Journal: Thorax Date: 2021-07-22 Impact factor: 9.139